Literature DB >> 3311225

Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.

N S Young1, E Leonard, L Platanias.   

Abstract

Clinical observations first suggested an immune basis for aplastic anemia. Laboratory studies have implicated a suppressor T lymphocyte producing molecules like gamma-interferon that inhibit hematopoiesis. Extrapolation from in vitro studies is complicated by synergy and antagonism among lymphokines and interleukins, the presence of regulators of proliferation produced by bone marrow cells, and possible differences between endogenous and exogenously administered molecules on cell growth.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311225

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  2 in total

1.  T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.

Authors:  Elena E Solomou; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 2.  Eltrombopag in aplastic anemia.

Authors:  Ronan Desmond; Danielle M Townsley; Cynthia Dunbar; Neal S Young
Journal:  Semin Hematol       Date:  2014-10-31       Impact factor: 3.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.